SNYR - Rasio Nilai Pasar marang Nilai Buku Synergy CHC Corp.

synergychc.com (SNYR) - logo korporat

Synergy CHC Corp (SNYR) holds assets in the beauty and health segment, where revenue stability is based on consistent retail demand. However, the company's profits are under pressure due to rising online promotion costs and competition with market behemoths, with the current figure standing at -0.04. The stock's price chart complements the data on this health-brand holding, which is attracting creative specialists to develop its e-commerce operations.

synergychc.com (SNYR) - Nilai Pasar marang Nilai Buku saka 24.10.2024 nganti 03.10.2026
Produk asil prodhuksi synergychc.com

The mvsbcap_co ratio determines the market price premium over the net asset value, revealing the gap between book valuation and investor expectations. Values above one indicate overvaluation or confidence in future growth. The price-to-book dynamics on GURU.Markets help identify trend reversal points. For Synergy CHC Corp (SNYR), this metric reflects the market valuation of the effectiveness of its strategy to acquire niche brands. The indicator demonstrates the extent to which market capitalization outpaces the value of acquired assets in the beauty and nutrition sector.

Analisis pesaing

Haleon plc (HLN) - Rasio Nilai Pasar marang Nilai Buku|kenvue.com - Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Verona Pharma|Jyong Biotech Limited - Kapitalisasi Pasar marang Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku LGND|AMRX (Amneal Corp) - Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku PRGO (Perrigo Company plc)|Rasio Kapitalisasi Pasar marang Nilai Buku alvotech.com ALVO|LQDA - Rasio Nilai Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku GLPG (Galapagos N.V.)|ANI Pharma (ANIP) - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Afrezza|AMPH (Amphastar Pharmaceuticals) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku pacira.com|Rasio Kapitalisasi marang Aset Bersih SPRY (ARS Pharmaceuticals, Inc.)|TBPH (Theravance Biopharma Inc) - Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Aquestive Pharma AQST|scPharmaceuticals, Inc. (SCPH) - Koefisien Nilai Pasar marang Nilai Buku|TECX: Rasio Kapitalisasi marang Aset Bersih|tonixpharma.com - Multiplikator Kapitalisasi Pasar marang Nilai Buku|SXTC: Rasio Kapitalisasi Pasar marang Nilai Buku|Eupraxia Pharmaceuticals Inc. - Nilai Pasar marang Nilai Buku|BHST (BioHarvest) - Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Invizyne EXOZ|Rasio Nilai Pasar marang Nilai Buku Oramed Pharmaceuticals (ORMP)|ENTX (enterabio.com) - Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku MindWalk Holdings Inc. HYFT|Kapitalisasi Pasar marang Nilai Buku ABVC BioPharma Inc. (ABVC)|CPIX: Rasio Kapitalisasi marang Aset Bersih|Koefisien Nilai Pasar marang Nilai Buku Quantum BioPharma Corp|FibroGen, Inc. (FGEN) - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku TELO|RANI (Rani Therapeutics Holdings) - Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Rallybio Corp. RLYB|Rasio Nilai Pasar marang Nilai Buku Lexaria Bioscience (LEXX)|PULM (Pulmatrix Corporation) - Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku PTHL (Pheton Holdings)|Rasio Nilai Pasar marang Ekuitas Aptorum Group Ltd|LYRA: Rasio Kapitalisasi marang Aset Bersih|Koefisien Nilai Pasar marang Nilai Buku impactbiomedinc.com|TNFA (tnfpharma.com) - Rasio Kapitalisasi marang Aset Bersih|cbdMD - Nilai Pasar marang Nilai Buku|PRFX (PainReform Ltd.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Auris Medical (CYTO)|Rasio Kapitalisasi Pasar marang Nilai Buku LIPO|OPTN (OptiNose Inc) - Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku PIRS (Pieris)|PROC - Rasio Kapitalisasi marang Aset Bersih|PTPI: Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku QLI (qlsyy.net)|SLRN: Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih TFF Pharmaceuticals Inc.